Oridonin: targeting programmed cell death pathways as an anti-tumour agent
Author:
Affiliation:
1. Department of Hepato-biliary Surgery; General Hospital of PLA; Beijing; China
2. State Key Laboratory of Biotherapy and Cancer Center; West China Hospital; Sichuan University; Chengdu; China
3. BeiGene (Beijing) Co., Ltd; Beijing; China
Publisher
Wiley
Subject
Cell Biology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2184.2012.00849.x/fullpdf
Reference75 articles.
1. Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo;Zhou;Blood,2007
2. Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells;Ikezoe;Int. J. Oncol.,2003
3. Back to the future of oridonin: again, compound from medicinal herb shows potent antileukemia efficacies in vitro and in vivo;Zhou;Cell Res.,2007
4. The hallmarks of cancer;Hanahan;Cell,2000
5. Targeting caspase-mediated programmed cell death pathways for cancer therapy;Wen;Cell Prolif.,2012
Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Integrating Epigenetics, Proteomics, and Metabolomics to Reveal the Involvement of Wnt/β-Catenin Signaling Pathway in Oridonin-Induced Reproductive Toxicity;Toxics;2024-05-07
2. Research and Development Progression of Oridonin for Hematological Malignancies Therapy;Current Medicinal Chemistry;2024-02-16
3. Terpenoid-Mediated Targeting of STAT3 Signaling in Cancer: An Overview of Preclinical Studies;Biomolecules;2024-02-07
4. Oridonin Promotes Apoptosis in Rheumatoid Arthritis Fibroblast-like Synoviocytes Through PERK/eIF2α/CHOP of Endoplasmic Reticulum Stress Pathway;DNA and Cell Biology;2023-12-01
5. Oridonin restores hepatic lipid homeostasis in an LXRα-ATGL/EPT1 axis-dependent manner;Journal of Pharmaceutical Analysis;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3